1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride
C15H16BrClFN5O — CID 120867125
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride
1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride (PubChem CID 120867125) has the molecular formula C15H16BrClFN5O and a molecular weight of 416.68 g/mol. Its IUPAC name is 1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride.
Molecular Properties
| Compound Name | 1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride |
|---|---|
| PubChem CID | 120867125 |
| Molecular Formula | C15H16BrClFN5O |
| Molecular Weight | 416.68 g/mol |
| Exact Mass | 415.02 |
| IUPAC Name | 1-[5-[4-bromo-1-(4-fluorophenyl)pyrazol-3-yl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-2-amine;hydrochloride |
| SMILES | CNC(C)Cc1noc(-c2nn(-c3ccc(F)cc3)cc2Br)n1.Cl |
| InChI | InChI=1S/C15H15BrFN5O.ClH/c1-9(18-2)7-13-19-15(23-21-13)14-12(16)8-22(20-14)11-5-3-10(17)4-6-11;/h3-6,8-9,18H,7H2,1-2H3;1H |
| InChIKey | GPMFVIWUHYXHNG-UHFFFAOYSA-N |
| XLogP | 3.40 |
| TPSA | 68.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 416.68 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120867125 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.